Michael Patriarco, DO
Obstetrics & Gynecology · Allentown, PANPI 1598860850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $930 of the $1,230 with a category attached, or 75.6%. 9 manufacturers reported payments, led by Minerva Surgical, Inc at 25.7% of the total. Reporting peaked in 2022 at $332 and has fallen 83.5% since, to $55 in 2024.
Across 21 payments — averaging $58.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Minerva Surgical, Inc$317
- Aesculap, Inc.$300
- Coloplast$154
- Johnson & Johnson$147
- Femselect Inc.$105
- Hologic Sales And Service, LLC$104
- plus $104 from 3 others
Across 11 payments — averaging $835.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$9K
What the payments were for
- Consulting fees$30024%
- Food & beverage$93076%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Minerva Surgical, Inc | 4 | $317 |
| Aesculap, Inc. | 1 | $300 |
| Coloplast | 5 | $154 |
| Johnson & Johnson | 4 | $147 |
| Femselect Inc. | 1 | $105 |
| Hologic Sales And Service, LLC | 3 | $104 |
| Myovant Sciences Inc. | 1 | $70 |
| Astellas Pharma US Inc | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,230 in reported general payments places this provider in the 75th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 209 | $19,282 |
| PremarinEstrogens, Conjugated | 20 | $5,693 |
| YuvafemEstradiol | 12 | $3,039 |
| Ibandronate Sodium | 71 | $2,081 |
| Solifenacin Succinate | 20 | $1,036 |
| Terconazole | 19 | $551 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $528 |
| ValacyclovirValacyclovir Hcl | 11 | $451 |
| Medroxyprogesterone Acetate | 17 | $304 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $210 |
| Fluconazole | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Allentown
- Joseph PatrunoAllentown$93K
- Theresa McClainAllentown$16K
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.